SEARCH RESULT

Total Matching Records found : 243

India's patent ruling on cancer may open door for cheaper HIV drugs

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times   The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Opposition to Monsanto patent on Indian melons by Gargi Parsai

Activist Vandana Shiva and an Europe-based NGO have jointly opposed a patent awarded to an American company on virus resistance traits taken from indigenous melon varieties in India. The NGOs — Navdanya and No Patent on Seeds — contend that, armed with this patent, the U.S. company (Monsanto) could block access to all breeding material inheriting the virus resistance derived from the Indian melon. Seeking complete revocation of the patent the NGOs,...

More »

GM crops have not lived up to their promises, say NGOs by John Vidal

Genetic engineering has failed to increase the yield of any food crop but has vastly increased the use of chemicals and the growth of “superweeds,” according to a report by 20 Indian, southeast Asian, African and Latin American food and conservation groups representing millions of people. The so-called miracle crops, which were first sold in the U.S. about 20 years ago and which are now grown in 29 countries on about...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close